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Abstract
Background: When purified phagosomes are incubated in the presence of actin under appropriate conditions, microfilaments
start growing from the membrane in a process that is affected by ATP and the lipid composition of the membrane. Isolated
phagosomes are metabolically active organelles that contain enzymes and metabolites necessary for lipid interconversion.
Hence, addition of ATP, lipids, and actin to the system alter the steady-state composition of the phagosomal membrane at the
same time that the actin nucleation is initiated. Our aim was to model all these processes in parallel.
Results: We compiled detailed experimental data on the effects of different lipids and ATP on actin nucleation and we
investigated experimentally lipid interconversion and ATP metabolism in phagosomes by using suitable radioactive compounds.
In a first step, a complex lipid network interconnected by chemical reactions catalyzed by known enzymes was modelled in
COPASI (Complex Pathway Simulator). However, several lines of experimental evidence indicated that only the
phosphatidylinositol branch of the network was active, an observation that dramatically reduced the number of parameters in
the model. The results also indicated that a lipid network-independent ATP-consuming activity should be included in the model.
When this activity was introduced, the set of differential equations satisfactorily reproduced the experimental data. On the other
hand, a molecular mechanism connecting membrane lipids, ATP, and the actin nucleation process is still missing. We therefore
adopted a phenomenological (black-box) approach to represent the empirical observations. We proposed that lipids and ATP
influence the dynamic interconversion between active and inactive actin nucleation sites. With this simple model, all the
experimental data were satisfactorily fitted with a single positive parameter per lipid and ATP.
Conclusion: By establishing an active 'dialogue' between an initial complex model and experimental observations, we could
narrow the set of differential equations and parameters required to characterize the time-dependent changes of metabolites
influencing actin nucleation on phagosomes. For this, the global model was dissected into three sub-models: ATP consumption,
lipid interconversion, and nucleation of actin on phagosomal membranes. This scheme allowed us to describe this complex
system with a relatively small set of differential equations and kinetic parameters that satisfactorily reproduced the experimental
data.
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When trying to understand complex signalling networks,
success depends on the ability of the investigator to access
the system in order to manipulate components and test
hypotheses; for this, a simple experimental system is
needed. For several years we have used latex bead phago-
somes (LBP) for in vitro and in vivo analyses of complex
membrane processes, due to the ease by which these
organelles can be isolated in pure form from macrophages
[1]. An additional advantage of these organelles for ana-
lyzing signalling networks is that the cytosolic side of the
membrane is exposed to the investigator. LBP represent
the simplest imaginable membrane system, a single
bilayer around a 1 μm latex bead. Nevertheless these
organelles are of amazing complexity, being composed of
at least 1000 so far identified proteins (Desjardins, per-
sonal communication) as well as hundreds, if not thou-
sands of lipids (Brouwers et al, personal communication).
Among these are functional units of proteins and lipids
that sense incoming signals, regulate fusion, and interact
with the cytoskeleton [1]. Since all these processes have
been reconstituted in vitro [2-5], the intricate membrane
machinery required for their operation must be function-
ally intact on these isolated membrane organelle.
In this study, we addressed the modulation by ATP and
lipids of the process by which LBP nucleate actin in vitro.
In this process, actin filaments grow out perpendicularly
from the membrane. On phagosomes, as in all known
examples of membrane-catalyzed actin assembly, actin
monomers are inserted at the membrane surface [6]. This
is a cytosol- and GTP-free reaction, requiring only G actin,
thymosin β4 (which works as a monomeric actin buffer),
and ATP. A number of proteins have been implicated in
this process, most prominently ezrin and/or moesin [7].
Interestingly, the process is highly sensitive to the lipid
composition of the membrane: addition of specific lipids
leads to pronounced differences in the response of phago-
somes to actin assembly, in a manner that varies with ATP
levels [4,8]. Phagosomes are metabolically competent, as
they contain enzymes and metabolites necessary for lipid
interconversion [4,8-11]. Therefore, the addition of ATP
and lipids to the incubation will provoke a perturbation
of the steady-state phagosomal membrane composition
attained after preparation of the organelle in a metabolite-
free medium. The dynamic rearrangement of the meta-
bolic state occurs simultaneously with the nucleation of
actin and the filament growth. Our aim here was to model
both processes, metabolic changes of ATP and lipids as
well as actin polymerization, in parallel. Towards this
goal, we compiled detailed experimental data on the
effects of different lipids and ATP on phagosome actin
assembly, and investigated lipid interconversion and ATP
metabolism in phagosomes experimentally by using suit-
able radioactive compounds. All the results were inte-
grated into a mathematical model that combined three
independent sub-models: ATP consumption, lipid inter-
conversion, and nucleation of actin on phagosomal mem-
branes. This division allowed to describe this complex
system with a relatively small set of differential equations
and kinetic parameters which satisfactorily reproduced
the experimental data.
Results
Fate of ATP during incubation with phagosomes
For this study, we used purified phagosomes made by
internalizing 1 μm latex beads, to which avidin had been
covalently attached, for 1 h pulse followed by 1 h chase.
The addition of 1 mM ATP to 2 h LBP induces the phos-
phorylation of many (unidentified) proteins by phago-
somal kinases [11]. ATP concentration also strongly
affects actin polymerization by phagosomes [7]. In addi-
tion, this nucleotide is a 'hub' molecule in several meta-
bolic routes, including phospholipid metabolism. We
therefore studied the fate of ATP in our phagosomal prep-
aration. Upon addition of γ32P-labelled ATP (γ32P.ATP),
radioactive phosphate was incorporated into several
phospholipids (see below), and presumably into pro-
teins, nucleotides and other metabolites. However, this
accounted only for a negligible fraction (less than one per-
cent) of the added ATP. The bulk of 32P appears as ortho-
phosphate and may be the consequence of unspecified
ATPase-like reactions in the phagosome membrane.
Phagosomes were incubated under the same conditions
used for actin polymerization and a fixed amount of
γ32P.ATP was added in the presence of varying concentra-
tions of unlabelled ATP. Lipids and proteins were dis-
carded following a methanol:chloroform extraction, and
free radiolabelled orthophosphate was separated from
ATP by TLC. In Fig. 1A, a typical experiment is shown. Two
non-specific phosphatase inhibitors, fluoride and vanad-
ate, inhibited γ32P.ATP hydrolysis, as well as addition of
unlabelled ATP (Fig. 1A). Apyrase completely degraded
ATP within 5 min. The time course of the γ32P.ATP
hydrolysis, expressed as a percentage of the respective ini-
tial value at different concentrations of unlabelled ATP is
shown in Fig. 1B. The decay rate apparently followed a
two-component exponential function. The rate of ATP
degradation showed a non-linear dependence on the ini-
tial concentration of unlabelled ATP, suggesting saturable
ATP-consuming reactions. We decided to fit the rates to
Michaelis-Menten-type kinetics. The decay curves were fit-
ted to the sum of two reactions with different characteris-
tics; one reaction that occurs already at low ATP
concentrations and has a low maximal velocity, and a sec-
ond reaction which becomes important only at much
higher ATP concentration but has a higher maximal veloc-Page 2 of 15
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ATP consumption by phagosomal preparationsFigure 1
ATP consumption by phagosomal preparations. Phagosomal preparations were incubated al 20°C with γ32P.ATP in the 
presence of different concentrations of unlabelled ATP and with the addition (when indicated) of 10 mM KF + 1 mM 
orthovanadate (F + V). Lipids and proteins were separated by a chloroform:methanol extraction and the water soluble radioac-
tive species were resolved by TLC. A. A typical TLC plate showing the time dependent ATP hydrolysis. Left most lane: 
γ32P.ATP (5X concentration) before adding to the phagosomal preparation. Right most lane: same γ32P.ATP aliquot incubated 
with 10 U/ml apyrase. B. The TLC plate of a typical experiment as shown in A was scanned and the percentage of non hydro-
lyzed γ32P.ATP was estimated. Experimental data are plotted as symbols; the model predictions as solid lines having the same 
colours than the corresponding experimental observations.
BMC Systems Biology 2008, 2:107 http://www.biomedcentral.com/1752-0509/2/107ity. The corresponding differential equation has the fol-
lowing form:
dATP/dt = - vh - vk
with
vh = Vh * ATP/(ATP + Kh) and vk = Vk * ATP/(ATP+ Kk)
where
vh and vk (ATP decay rates)
ATP (actual ATP concentration at time t)
Vh and Kh (maximal rate and concentration for half-maxi-
mal rate of the rapid ATP decay)
Vk and Kk (maximal rate and concentration for half-maxi-
mal rate of the slow ATP decay)
The differential equation was solved for specified param-
eter values and initial concentrations by using the Com-
plex Pathway Simulator (COPASI) software (see
Additional file 1). A parameter estimation routine, also
performed by COPASI, allowed a search for Vh, Kh, Vk, and
Kk values to produce an optimal fit (defined as minimal
sum over all squared differences between experimental
and predicted concentrations). The results are indicated in
Table 1 together with an estimator of the sensitivity of the
fitting to parameter perturbation (described in Methods).
As shown in Fig. 1B, the coincidence of prediction and
measurement was satisfactory, with a tolerable systematic
scatter of experimental values around the model predic-
tion (for clarity, only one of the two experiments used for
the calculations is plotted). The deviation of theory from
the experimental data was about 14%, using squared devi-
ations, or 10%, using absolute deviations as criterion (see
Methods). In conclusion, the ATP concentration in the
system showed dynamic changes, implying that actin
polymerization occurred in an 'evolving' environment.
This time-dependent ATP consumption was taking into
account when the lipid network and the assembly of actin
filaments were modelled (see below).
Lipid network dynamics
From previous experiments we knew that certain phos-
phorylated and non-phosphorylated lipids modulate
actin assembly [8,9]. Fig. 2A shows a simplified metabolic
network based on accepted biochemical knowledge http:/
/www.brenda-enzymes.info/ that connects several lipids
affecting actin polymerization on phagosomal mem-
branes. In this scheme, except for diacylglycerol (DAG),
all other molecules are phospholipids. We also summa-
rize the effect on actin filament assembly of these lipids
when added to the system (symbols in brackets). It is
impossible to decide a priori whether any of the effects on
actin assembly is direct or indirect (i.e., through conver-
sion of one lipid into another directly-acting metabolite
during the incubation in the presence of ATP). Therefore,
to separate the effect of lipids, it was necessary to first
assess the dynamics of these molecules in the isolated
phagosomes. A powerful method to analyze the phos-
pholipid metabolism in a system is to follow the incorpo-
ration of 32P from the γ-phosphate of radiolabelled ATP.
We therefore performed experiments where γ32P.ATP was
incubated during different periods of time with phago-
somal preparations under the same conditions as used for
actin polymerization. Lipids were extracted with chloro-
form:methanol and radioactive lipids resolved by TLC.
Three prominent spots were consistently seen, corre-
sponding to the remaining ATP (staying at the origin),
and to phosphatidylinositol-4-phosphate (PIP) and phos-
phatidylinositol-4,5-bisphosphate (PIP2, Fig. 3A). The
optical density of these spots is approximately propor-
Table 1: Parameter estimation for ATP consumption (sub-
model I)
Parameter units Value sensitivity (ΔlnSS/Δlnp)
Vh μmol/(l*min) 24.3 0.272
Kh μmol/l 758 0.046
Vk μmol/(l*min) 1.08 0.069
Kk μmol/l 4.72 0.072
The results of two independent γ32P. ATP hydrolysis experiments 
and the COPASI program were used to estimate parameters. 
Sensitivity for each parameter was calculated as explained in Methods.
A simplified lipid network interconnecting several species that affect actin nucleation on purified phagosomesFigure 2
A simplified lipid network interconnecting several 
species that affect actin nucleation on purified phago-
somes. The qualitative effect on actin nucleation is shown in 
brackets (+, activation; -, inhibition; 0, no effect). B. Branch of 
the network shown in A that was found to be active in puri-
fied phagosomal fractions. The numbers refer to the reac-
tions in sub-model II. In red are the radioactive species 
detected in the experimental assays (see Fig. 1 and 3).Page 4 of 15
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Phospholipid metabolism in phagosomal preparationsFigure 3
Phospholipid metabolism in phagosomal preparations. A. A phagosomal preparation was incubated with γ32P.ATP and 
0.1 mM unlabelled ATP at 20°C for different periods of time (min). Phospholipids were extracted with chloroform:methanol 
and resolved by TLC. The plate was exposed for 8 h (left) or 24 h (right). B. A phagosomal preparation was incubated with 
14C(glycerol).PA (14C.PA) or 3H(choline).PC (3H.PC), 0.2 mM unlabelled ATP and (when indicated) 1 mM CTP and 1 mM 
inositol for different periods of time (min). Phospholipids were extracted and resolved by TLC. C. A phagosomal preparation 
was incubated with γ32P.ATP and 0.2 mM unlabelled ATP in the presence of different concentrations of unlabelled PC, PA, and 
DAG (μM) for 15 min. Phospholipids were extracted and resolved by TLC. Radiolabelled PA and PC were included in the right 
most lane as markers. Only the upper part of the TLC plate is shown. D. In experiments similar to the one shown in C, differ-
ent concentrations of unlabelled lipids (μM) were included in the assay. The amount of 32P incorporated in PIP and PIP2 was 
quantified and expressed as a percentage of the incorporation observed when no lipid was added. The values represent the 
mean of 2 or 3 independent experiments (error bars: range for N = 2, SEM for N = 3).
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the end of the incubation. The concentration of PIP was
always higher than that of PIP2, in agreement with previ-
ously published results [4]. Only few radioactive com-
pounds were observed migrating faster than PIP, even
after over-exposing the TLC plates (Fig. 3A, right set of
lanes). The absence of bands in the locations of phospha-
tidic acid (PA), phosphatidylinositol (PI) and phosphati-
dylcholine (PC) -the other phosphate-containing lipids in
the network, that should migrate above PIP in this TLC
system- showed that there was little incorporation of 32P
into these compounds; the kinases and transferases
required for their synthesis are likely inactive. An uniden-
tified band was seen in the solvent front and its identifica-
tion was not pursued further. To confirm that the
branches involving PA and PC are less active, we incu-
bated 14C.PA or 3H.PC with phagosomes for extended
periods of time. Fig. 3B shows that during incubation nei-
ther lipid was metabolized to other species indicating that
the conversions of PA to PI or DAG, as well as of PC to PA
or DAG were not active. PA did not change even if CTP
and inositol (cofactors of the metabolic pathway towards
PI) were added to the assay (Fig. 3B). We further tested
whether the addition of unlabelled PA, PC or DAG could
affect the incorporation of 32P into phosphorylated lipids.
PC had no effect while PA and DAG slightly increased the
incorporation of 32P into the fast moving lipid and into an
unidentified phospholipid migrating close to PC on the
TLC plate (Fig. 3C). However, up to 200 μM DAG did not
promote any significant increase of radiolabelled PA, even
after exposing the TLC plates for long periods of time (Fig.
3C). This observation indicates that DAG is not actively
phosphorylated to PA in the phagosome by a DAG kinase
activity. Fig. 3D shows that relatively high concentrations
of PC, PA, or DAG, all of which affected actin polymeriza-
tion (see below) only slightly altered the synthesis of PIP
and PIP2.
We also tested whether addition of soluble cofactors that
participate in lipid interconversion could promote 32P
incorporation. To this end, CTP, choline, and inositol
were added in combination with PA or DAG. However,
labelling of PI or PC was not observed (data not shown).
The only relevant effect was that CTP inhibited the incor-
poration of 32P into PIP and PIP2 (data not shown). This
is likely to be due to a dilution effect, caused by ATP syn-
thesis from unlabelled CTP by nucleoside diphosphoki-
nase.
In conclusion, the observations with labelled and unla-
belled lipids indicate that the only network branch meta-
bolically active in the 2 h LBP is the synthesis and
consumption of PIP and PIP2. The dynamically relevant
phospholipid subsystem is depicted in Fig. 2B. The
enzyme reactions indicated by numbers 1 through 5 -
together with documented in vitro kinetic parameters [12-
14]- are:
Reaction 1: PI-4kinase (2.7.1.67 Km = 115 μM for PI; Km
= 150 μM for ATP)
Reaction 2: PIP-5kinase (2.7.1.68; Km = 5 μM for PIP; Km
= 19 μM for ATP)
Reaction 3: phosphoinositide phospholipase C (3.1.4.11;
Km = 170 μM for PIP2)
Reaction 4: phosphoinositide phospholipase C (3.1.4.11;
Km = 130 μM for PI)
Reaction 5: phosphoinositide phospholipase C (3.1.4.11;
Km = 310 μM for PIP)
We derived a system of differential equations describing
the time course of those metabolites that change concen-
tration during incubation. In this system, ATP consump-
tion was described as an independent subsystem with
reactions vh and vk, as parameterized above. The fitting of
ATP's influence on kinase reactions 1 and 2 required satu-
rable (Michaelis-Menten) kinetics. Simple linear rate laws
did not produce satisfactory 'fits' (results not shown).
Moreover, the published Km for reaction 2 was in the
micromolar range for PIP; a value that is likely lower than
the actual lipid concentration in the membranes when
this compound is added to the system (see below). Hence,
a saturable kinetics was used for PIP. For the other reac-
tions, mass-action kinetics proved satisfactory. The result-
ing system of differential equations describing this system
reads:
d(PI)/dt = - v1 - v4 (PI is being consumed from an initial
concentration)
d(PIP)/dt = v1 - v2 - v5 (PIP is being produced by one and
consumed by two reactions)
d(PIP2)/dt = v2 - v3 (PIP2 is being produced and con-
sumed)
d(DAG)/dt = v3 + v4 + v5 (DAG accumulates during the
incubation)
with
v1 = V1 * PI * ATP/(ATP+K1)
v2 = V2 * PIP/(PIP+K3) * ATP/(ATP+K2)
v3 = k3 * PIP2Page 6 of 15
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v5 = k5 * PIP
where the k's are rate parameters, the K's are Michaels half-
maximal activity parameters, V's are maximal rates, and
the metabolite acronyms (PI, PIP, PIP2, DAG, ATP) stand
for their time-variable concentrations. Initial lipid con-
centrations in the phagosomal membrane were estimated
as 266 μM PC, 49 μM PI, 2.5 μM PIP, 0.25 μM PIP2, 10
μM PA, 7.4 μM DAG (see "Phagosomal lipid assump-
tions" in Methods). The uncertainty in these values is con-
siderable. Fortunately, it turned out that our conclusions
were not strongly affected by changes in the initial lipid
concentrations (see below).
With rate parameters and initial conditions specified, the
software COPASI solves the time-course for all implicated
metabolites (see Additional file 2). Furthermore, a param-
eter estimator (in COPASI) can fit the parameters to
describe the actually measured time-concentration matrix
of PIP and PIP2 in the least-squares' sense. For this, the
time courses of 32P incorporation into PIP and PIP2 at dif-
ferent ATP concentrations were used. The results of only
two experiments were included for parameter estimation;
however, qualitatively similar results were obtained in a
total of five independent experiments. The results of
parameter estimation are given in Table 2 together with an
estimator of the sensitivity of fitting to parameter pertur-
bations. Fig 4A shows fitted and measured 32P-labelled
PIP and PIP2 values (for clarity, only one of the two exper-
iments used for the calculations is plotted). The deviation
of the model from the experimental data was estimated to
be about 18% (squared deviations) or 15% (absolute
deviations), which indicates a tolerable systematic scatter
of experimental values around the model prediction.
Several other experiments were performed to test the
model. In one experiment, phagosomes were incubated
with only unlabelled ATP and after different times of pre-
incubation, γ32P.ATP was added and incorporation of
32P into PIP was analyzed (Fig. 4B, left panel). In a differ-
ent set of experiments, after 10 min incubation with
γ32P.ATP, apyrase was added to the system and the label-
ling in PIP was followed for several minutes (Fig. 4B, right
panel). The model agreed well with the experimental
results, indicating that the reactions included in the
model and the parameters selected are a good description
of the phagosomal lipid network. Note that in the case of
the enzyme kinetic K parameters, the estimates are in rea-
sonably good agreement with the reported Km constants.
Note also that the three phospholipase C (PLC)-like reac-
tions (reactions 3, 4, and 5, Fig. 2B) have similar k param-
eters. Moreover, the sum of squared deviations between
data and prediction was not significantly affected when a
single k parameter was used for all three phosphatases.
The model predicts the following time course characteris-
tics for radioactive lipid dynamics that accurately repro-
duce the experimental observations (Fig. 3): 1. 32P is
continuously incorporated in PIP and PIP2, a process that
is limited by the consumption of γ32P.ATP. 2. Most of the
ATP consumption is caused by the ATPase reactions
included in the model. 3. At low ATP concentrations, the
nucleotide is rapidly consumed, but incorporation into
phospholipids is efficient because there is no competition
with unlabelled nucleotide. In contrast, at high ATP con-
centrations, the label is incorporated at a slower rate
(because of competition by unlabelled ATP), and no max-
imum level is reached during the incubation period. 4.
PLC-like reactions slowly remove the radioactive phos-
phate from the lipids.
For the actin nucleation process it was important to ana-
lyze the changes in concentration of unlabelled lipids pre-
dicted by the model. With 200 μM ATP, PI and PIP were
slowly consumed. The concentration of PIP2 was main-
tained at quite stable values (Fig. 4C, left panel). At higher
ATP concentrations, this nucleotide and PIP were con-
sumed at a slower rate, whereas the kinetics of PI con-
sumption did not change significantly. PIP2 slightly
increases during the incubation (Fig. 4C, right panel).
DAG, the final product of reaction 3, 4, and 5, accumu-
lated with similar kinetics at low and high concentrations
of ATP (not shown).
Modelling of the actin assembly process
Phagosomes are able to nucleate microfilaments in vitro
when incubated in the presence of actin. During this proc-
ess the actin monomers are somehow inserted into the fil-
aments at the surface of the membrane and 'treadmill'
outwards from this site towards the depolymerizing
pointed end at the opposite side of the filament. In this
poorly understood process, all the molecular machinery
involved is present on the isolated phagosomes; no
Table 2: Parameter estimation for the lipid network (sub-model 
II)
Parameter units Value sensitivity (ΔlnSS/Δlnp)
V1 1/min 0.00106 0.455
K1ATP μmol/l 159 0.354
V2 μmol/(l*min) 0.0139 0.575
K2ATP μmol/l 62.9 0.424
K2PIP μmol/l 5.00 0.051
k3 1/min 0.0175 0.361
k4 1/min 0.0209 0.154
k5 1/min 0.0226 0.454
The results of two independent experiments of 32P-incorporation into 
lipids and the COPASI program were used to estimate parameters. 
Sensitivity for each parameter was calculated as explained in Methods.Page 7 of 15
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Experimental and model values for 32P incorporation in PIP and PIP2Figu e 4
Experimental and model values for 32P incorporation in PIP and PIP2. A. Phagosomal preparations were incubated 
with γ32P.ATP at 20°C for different periods of time in the presence of different concentrations of unlabelled ATP. Phospholip-
ids were extracted with chloroform:methanol and resolved by TLC. The radioactivity incorporated in PIP and PIP2 was meas-
ured and calibrated with a γ32P.ATP standard. B. Left panel. Phagosomal preparations were pre-incubated with 0.2 mM cold 
ATP at 20°C for 0, 15, 30 or 60 min. Afterwards, γ32P.ATP was added and the samples were incubated for 0, 1, 2, and 4 min. 
Right panel. Phagosomal preparations were incubated with γ32P.ATP in the presence of 50 μM unlabelled ATP for 10 min at 
20°C. Apyrase (0 or 1 U/ml) was then added to samples (arrow) and the incubation continued for 0, 5, 10, or 22 min. Radiola-
belled PIP was measured as in A. For A and B, experimental data are plotted as symbols; the model predictions as solid lines 
having the same colours than the corresponding experimental observations. C. Model predicted variation of ATP and phos-
pholipids at two concentration of ATP: 0.2 mM (left panel) and 3.2 mM (right panel).
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experiments, it was known that lipids have a strong influ-
ence on this process. Fig. 2A shows the network of relevant
lipids that were systematically tested in the actin nuclea-
tion assay. Other lipids not included in this network are
also able to influence actin nucleation [8]; however, as a
first approach, we only included lipids in a simple inter-
connected network whose time course of interconversion
was experimentally accessible. Because of the well-estab-
lished observation that phagosomes nucleate actin more
efficient at low (0.2 mM) than at high (5 mM) concentra-
tions of ATP, the whole set of lipids was tested at low and
high concentrations of this nucleotide.
ATP and lipids probably affect actin nucleation through
complex interactions with proteins. However, detailed
molecular mechanisms for these interactions are still
missing. We therefore adopted a phenomenological
(black-box) approach to represent the empirical observa-
tions. As presently understood, actin filaments grow from
membranes at specific nucleation sites. Therefore, we
assumed that lipids and ATP would influence the number
of active nucleation site on the membranes. Phagosomes
were classified as positive (having one or more nucleation
sites polymerizing actin) or negative (lacking any nuclea-
tion site polymerizing actin). Initial concentrations for
lipids under control conditions (i.e., no lipid addition)
were set as explained for sub-model II. From experiments
with radioactive PC, PA, PIP, and PIP2, the amount of
lipid incorporated in phagosomes after addition to the
phagosomal fraction was estimated (see "Lipid incorpora-
tion into phagosomes" in Methods). PC has a strong
inhibitory effect on actin nucleation at relatively low con-
centrations. Since this lipid is very abundant in the mem-
branes, we reasoned that externally added PC and the
endogenous PC may have different effects on actin nucle-
ation and we therefore considered both as different spe-
cies. Accordingly, PC in the control conditions was set to
zero and to 0.8 μM after PC addition. We developed a
minimal phenomenological model that was able to
describe the observed experimental results.
This model assumes that actin nucleation sites can be in
three configurations: inactive (unable to nucleate actin fil-
aments, ni), active (able to nucleate actin filaments, na)
and polymerizing actin filaments (naActin). The nuclea-
tion sites are activated with a certain rate va or inactivated
with rate vi. Active nucleation sites (na) initiate actin
polymerization with rate vg proportional to the actual
(time-variable) concentration. The nucleation sites that
are growing actin filaments (naActin) cannot be inacti-
vated. The amount of naActin on the preparation was esti-
mated from the percentage of phagosomes growing actin
filaments. Finally, from experimental observation, it was
known that the number of positive phagosomes reaches a
plateau after 15 min, and then remains stable for about
one hour. Therefore, we looked for a model that leads to
a plateau with this kinetics. The process was described by
the following two-dimensional system of differential
equations:
d(na)/dt = va - vi - vg (changes in the number of active
nucleation sites with time)
d(ni)/dt = - va + vi (changes in the number of inactive
nucleation sites with time)
with
va = ka * fi * ni (rate of nucleation sites activation)
vi = ki * fa * na (rate of nucleation sites inactivation)
vg = kg * na (rate of actin filaments nucleation)
fa = exp {- (pPI * PI + pPIP * PIP + pPIP2 * PIP2 + pPA * 
PA*ATP) }
fi = exp {- (qATP * ATP + qPC * PC + qDAG * DAG) }
The terms fa and fi stand for the modifying effect of ATP
and lipids (if present at a certain concentration) on actin
nucleation. The COPASI software allowed us to solve
these equations on specified parameter and initial values,
followed by least-square-guided parameter optimization
(see Additional file 3). Several different formulations were
tested for fa and fi. The negative exponential proved to be
the most suitable. Least-square-optimization rendered "p"
parameters for inhibitory factors (i.e., ATP, PC, and DAG)
and "q" parameters for activating or neutral factors (i.e.,
PI, PIP, PIP2, and PA) very close to zero. Hence, these
parameters were set to zero and the model simplified to a
single parameter per factor ("p", for activating or neutral
factors; "q" for inhibitory factors). With this simplified
model, only positive parameters were obtained after opti-
mization. For PI, a lipid with no effect on actin nuclea-
tion, "p" was also close to zero. fa and fi dynamically
change with time as ATP is consumed and lipid concentra-
tions change with time. Note that fa and fi have positive
values limited to the 0-to-1 range. Hence, activators (PIP,
PIP2, PA) affect actin nucleation by blocking vi, keeping
the nucleation sites in the active form. In contrast, inhibi-
tors (ATP, DAG, PC) slow down va, preventing re-activa-
tion of these sites (Table 3). For PA, which has an
activating effect only at high ATP concentrations, best fit-
ting was observed using a single "p" parameter affecting
an interaction product ATP*PA (Table 3).
n n n Actini
v
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rily (Fig. 5A to 5F). Its deviation from the experimental
data was about 13% (squared deviations) or 8% (absolute
deviations), which indicates that the model has the flexi-
bility to reproduce the experimental observation. One
must keep in mind that the uncertainty in the lipid con-
centrations in the phagosomal membrane is large (see
"Phagosomal lipid assumptions" and "Lipid incorpora-
tion into phagosomes" in Methods). However, by adjust-
ing the "p" and "q" parameters, the model can correctly
predict the changes in actin polymerization observed
using a broad set of " initial" and "after addition" lipid
concentrations (calculations not shown).
We have experimentally tested some non-trivial predic-
tions of the model. It is important to stress that the set of
parameters was not adjusted to fit the results of these
experiments. The dependency of actin nucleation on ATP
concentration was first assessed. As shown in Fig. 5G, the
concentration-dependent inhibition curve predicted by
the model closely followed the experimental data. We also
tested an 'order-of-addition' experiment. The interesting
feature in this protocol is that both conditions contain the
same added reagents during the actin nucleation step.
However, the model predicts poor actin nucleation when
an inhibitory lipid is added first (in the absence of actin)
and an activating lipid is added later together with actin.
The inhibitory lipid prevents reactivation of inactive
nucleation sites, which accumulate during the pre-incuba-
tion (va < vi). When the activating lipid is added, it blocks
vi and some sites are reactivated, but not enough to render
an efficient actin nucleation process (Fig. 5H). In contrast,
efficient nucleation is expected if the order of addition is
reversed (i.e., first the activating lipid and then the inhib-
itory one together with actin). During the pre-incubation,
the activating lipid prevents inactivation of active nuclea-
tion sites (va > vi). When the inhibitory lipid is added it
also blocks va, but the active sites present are enough to
polymerize actin filaments (Fig. 5I). Consistent with the
model, low values of actin nucleation were observed
when the inhibitory lipid was added first and high values
when it was added later, together with actin (red circles in
Fig. 5H and 5I). In conclusion, the simple model pre-
sented for actin nucleation on phagosomal membranes
can account for all the lipid and ATP effects observed.
Discussion
The membrane of the latex bead phagosomes isolated
from J774 macrophages is a complex, metabolically active
system. Here we initiated a global analysis of the dynam-
ics of a sub-set of interactions that occur on phagosomes
in response to ATP and different lipids that are involved in
the regulation of de novo membrane-catalyzed actin
assembly. Our results from a simplified bead-membrane
phagosome system can be expected to provide the foun-
dation for later investigations of the much more complex
situation when the bead is replaced by a live pathogen
such as Mycobacterium tuberculosis. A particularly challeng-
ing step in modelling the latex bead phagosome system
was to select a qualitatively correct set of equations that
accurately represent the processes occurring in the system.
In a first step, we modelled a complex lipid network -con-
taining most of the species we have identified that affect
actin nucleation- interconnected by chemical reactions
catalyzed by known enzymes (Fig. 2A). However, when
experiments were performed, only the phosphatidylinosi-
tol branch of the network was found to be active. Several
independent experimental lines of evidence support this
conclusion, i) in the presence of radioactive ATP, 32P was
incorporated almost exclusively in PIP and PIP2, ii) radi-
olabelled PA and PC were not actively metabolized by
phagosomes, and iii) addition of unlabelled PI, PA, and
DAG, only slightly affected the incorporation of 32P into
lipids. These observations forced us to change the model
to a more limited network of interconnected lipids (Fig.
2B). However, the problem was not completely solved.
We could not find a set of parameters for the enzymatic
reactions in the phosphoatidylinositol branch that repro-
duced the kinetics of incorporation of 32P into PIP and
PIP2. A reaction in the model was missing and the data
pointed to an ATP-consuming activity. When this reaction
was included, the model reproduced the experimental
data fairly accurately. The presence of an ATP-consuming
reaction was tested experimentally; we clearly detected
this activity and found that it was saturable, and that two
independent reactions produced a better 'fit' of our exper-
imental data. The latter were then used to parameterize
what we refer to as sub-model I. The incorporation of32P
into PIP and PIP2 by the phagosomal membrane reached
a plateau after a few minutes. According to the model, the
plateau was caused by depletion γ32P.ATP. Since the ATP
hydrolytic activities were saturable, the model predicted
that addition of unlabelled ATP should postpone the
appearance of the plateau, a prediction that was con-
Table 3: Parameter estimation for actin nucleation (sub-model 
III)
Parameter units Value sensitivity (ΔlnSS/Δlnp)
pPI l/μmol 0.00 -
pPIP l/μmol 0.724 2.18
pPIP2 l/μmol 0.819 0.96
pPA*ATP l2/μmol2 3.05E-05 1.08
qATP l/μmol 0.00085 0.61
qDAG l/μmol 0.312 3.28
qPC l/μmol 1.83 0.36
The results of actin nucleation (mean of 3 to 5 independent 
experiments) in the presence of 0.2 or 5 mM ATP with the addition of 
different lipids and the COPASI program were used to estimate 
parameters. Sensitivity for each parameter was calculated as explained 
in Methods.Page 10 of 15
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Experimental and predicted values for actinnucleationFigu e 5
Experimental and predicted values for actinnucleation. A to F. Effect of ATP and lipids. Phagosomal preparations were 
incubated with actin and 0.2 mM (red) or 5 mM (blue) ATP. The percentage of phagosomes nucleating actin was measured 
under control conditions (estimated initial lipid concentrations in "Phagosomal lipid assumptions", Methods) or after addition 
of a single lipid (estimated initial concentration in "Lipid incorporation into phagosomes", Methods). For all panels, the percent-
age of positive phagosomes was used to estimate the number of active sites polymerizing actin (naActin) and expressed in arbi-
trary units (AU). G. naActin was estimated when the assay was supplemented with different concentrations of ATP. Symbols in 
panels A to G: experimental naActin ± SEM (N = 3–5); the model predictions are shown as solid lines having the same colours 
than the corresponding experimental observations. H. Phagosomal preparations were incubated first with DAG and 0.2 mM 
ATP. After 5 min, PIP was added to the assay together with actin, and the percentage of phagosomes nucleating actin was 
measured. I. Same protocol as in H, except that PIP was added during the preincubation and DAG together with actin. In H and 
I, the predicted number of inactive sites (ni, black lines), active sites (na, blue lines) and active sites nucleating actin (naActin, red 
lines) are shown together with the experimental values [naActin(e), red circles ± SEM, N = 3].
BMC Systems Biology 2008, 2:107 http://www.biomedcentral.com/1752-0509/2/107firmed experimentally. Among other data, we used in par-
ticular these experiments to adjust the parameter set for
sub-model II.
In brief, the final set of equation described in sub-model I
and II was established by a dynamic interplay between
modelling and experiments. It is worthwhile noticing that
the experiments were performed with several different
phagosomal preparations over several months. Moreover,
some experimental results reproduced observations pub-
lished 6 years ago [4]. Therefore, we are confident that
sub-model I and II faithfully represent the actual process
of ATP consumption and lipid interconversion occurring
in the phagosomal membrane.
A molecular mechanism connecting membrane lipids,
ATP, and the actin nucleation process is still missing. We
therefore adopted a phenomenological approach to repre-
sent the empirical observations. Three simple reactions
were included in sub-model III. According to experimen-
tal data, actin filaments start growing from defined points
in the membrane where G actin is recruited and assem-
bled into an initial filament by a molecular complex that
includes ezrin and/or moesin proteins in combination
with N-Wasp (Marion et al, in preparation). Although the
complexity of the actin assembly reactions on the mem-
brane defies a simple model, it is reasonable to believe
that these proteins are in equilibrium between an assem-
bled, active complex, ready to start the actin nucleation
process and inactive, partially assembled complexes. We
propose that lipids and ATP influence the dynamic inter-
conversion between active and inactive actin nucleation
sites. The third reaction -which we propose to be irrevers-
ible- is the growing of a filament from an active nuclea-
tion site. Experimental observations indicate that the
length of the actin filaments growing from the phago-
somes increases with time, suggesting that once a nucleat-
ing site is polymerizing actin, it remains active for a
relatively long period of time.
Several functions for the influence of lipids and ATP on
actin nucleation were tested. The best fitting with a mini-
mum number of parameters was obtained with a negative
exponential function. With this simple equation, all the
experimental data were satisfactorily fitted with a single
positive parameter per lipid and ATP. Qualitatively, the
exponential function can be approximately transformed
and interpreted by setting exp{-p*P} = 1/(1+p*P) (p
being an association constant and P the effector concen-
tration), which is approximately valid if p*P is close to
zero. This approximation displays lipids and ATP as
inhibitors of the respective nucleation sites activation and
inhibition reactions. The fact that the negative exponen-
tials fit better than the inhibitor binding kinetics is prob-
ably due to inhomogeneous binding kinetics extending
over a larger concentration range. The functional interac-
tion between lipids, ATP, and nucleation site factors is
complex, and the logarithmic concentration scale
(implied by exponentiation) covered the phenomena bet-
ter than any binding model based on linear concentration
scales.
The uncertainty in the lipid composition on phagosomal
membranes, both before and after lipid additions, is large;
however, the model was reasonably robust to changes in
these values. By adjusting the "p" and "q" parameters, rea-
sonably good fitting was obtained assuming very different
lipid concentrations. Analyzing the curve slopes in Fig. 5A
to 5F, at physiological concentrations of ATP (about 5
mM) actin nucleation was very sensitive to changes in PA,
PIP, and PIP2, suggesting that these lipids are necessary to
prevent inactivation of active sites. In contrast, at reduced
concentrations of ATP (i.e., 0.2 mM), the process was con-
stitutively activated. Addition of PIP and PIP2 further
stimulates actin nucleation while the inhibitory lipids
DAG and PC strongly inhibit this process. It was surpris-
ing that PIP has a direct role in stabilizing actin nucleation
sites and not an indirect effect through the generation of
PIP2 that is in general the lipid that binds proteins partic-
ipating in acting nucleation [15]. This latter lipid contrib-
utes to the negative charge of the lipid bilayer, a physical
property that may be important to stabilize active nuclea-
tion sites [16]. PC is one of the most abundant lipids in
biological membranes. However, external addition of PC
to tissues or cell cultures has strong biological effects. For
example, in Caco-2 cells, μM concentrations of PC in the
medium have a remarkable anti-inflammatory effect [17].
Actin nucleation on phagosomes is also very sensitive to
the addition of low concentrations of this lipid. The exter-
nally added lipid may interact with proteins in a different
manner than endogenous PC [17] or the fatty acid com-
position of the added PC may be different. We have
observed that PC carrying an arachidonic acid molecule (a
strong activator of actin nucleation) is not inhibitory in
the actin nucleation assay [17].
Conclusion
Actin nucleation on phagosomes and its regulation by
ATP and lipids involves numerous multi-component
interactions. Our knowledge about the molecular and
biochemical machinery active in this complex system is
very limited. Moreover, our knowledge is not balanced:
more is known about the biochemistry of the lipids inter-
conversion than about the actin nucleation site dynamics.
To overcome these difficulties, we have modelled the
process using a three-step approach. Sub-models I and II
are based on known chemical reactions connecting ATP
and the lipid of interest. Experimental data were used to
narrow the large set of possible reactions, allowing a satis-
factory predictive model containing a few parameters. InPage 12 of 15
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description in terms of a very simple system of differential
equations was developed. In this case also, a convenient
fitting of the experimental data was obtained with a rela-
tively small set of parameters. Although in its present form
sub-model III works as a black box with no details about
the factors involved, it can be easily decomposed to incor-
porate specific lipid or ATP influences on defined reac-
tions. Experimental work assessing the role of specific
proteins containing lipid-binding domains on actin
polymerization will be necessary to unveil the molecular
mechanism underlying the actin polymerization process
modelled here.
Methods
Reagents
Phosphatidylinositol-4-phosphoate (from brain), Phos-
phatidylinositol-4,5-bisphosphate (from brain), diacylg-
lycerol, and phosphatidylcholine were from Avanti Polar
Lipids, Inc. (Alabaster, USA). Phosphatidic acid, and
phosphatidylinositol were from Sigma Chemical Co. (St.
Louis, USA). All other reagents were from Sigma Chemical
Co. or Merck Chemicals (Darmstadt, Germany). Radioac-
tive phosphatidylcholine (L-α-dipalmitoyl, [choline-
methyl-3H]) and phosphatidic acid (L-α-dipalmitoyl,
phosphatidic acid, - [glycerol-14C(U)]) were from Perk-
inElmer Inc (Waltham, USA).
Actin nucleation assay by fluorescence microscopy
This assay has been previously described [7]. Briefly, glass
slides were coated with 0.5% fish-skin gelatin in water and
air-dried before the experiment. A constant number of
phagosomes (Optical Density at 600 nm, OD600 = 10) was
incubated between a slide and a coverslip in P buffer (20
mM HEPES, pH 7.0, 50 mM KCl, 4 mM MgCl2, 0.2 mM
CaCl2, 0.2 mM ATP, 0.03% fish-skin gelatin, and protease
inhibitors) with 2 μM rhodamine G-actin, 6 μM thymosin
β4, and an antifade reagent at room temperature for 15
min. The proportion of positive phagosomes was estab-
lished by counting at least three different microscope
slides in a Zeiss Axioscope microscope (Zeiss, Oberko-
chen, Germany). The proportion was converted to
number of nucleation sites polymerizing actin (naActin)
considering that any positive phagosome has at least one
naActin and that the distribution of nucleation sites per
phagosome follows a Poisson distribution. We considered
these numbers as arbitrary concentration units.
Phagosomal lipid assumptions
Total protein concentration measured by Bradford's
method in phagosomal preparations (OD600 = 10) was
1.2 ± 0.14 mg/ml (mean ± SD, N = 3). The phospholipid/
protein ratio reported for synaptic vesicles is 0.515 (mg/
mg) [18]. Assuming an average molecular weight for
membrane lipids of 1000 Da [19], the molar concentra-
tion would be 0.515 μmol/mg of protein. A comparable
concentration (0.282 μmol phospholipids/mg of protein)
has been reported for latex bead-containing phagosomes
from Acanthamoeba castellanii [20]. Hence, a 0.618
mM.phospholipid concentration was estimated for
phagosomal preparations having 1.2 mg/ml of total pro-
teins. Relative endogenous lipid molar ratios (referred to
total phospholipid in the sample) in our phagosomal
preparations were estimated from an ongoing lipidomic
analysis of latex bead phagosomes: 43% PC, 8% PI,
1.6%PA, and 1.2%DAG (J. Brouwers and B. Helms, per-
sonal communication). Relative concentrations for PIP
(0.4%) and PIP2 (0.04%) were estimated from the litera-
ture [21,22]. Endogenous lipid concentrations were then
estimated as: 266 μM PC, 49 μM PI, 2.5 μM PIP, 0.25 μM
PIP2, 10 μM PA, 7.4 μM DAG.
Lipid incorporation into phagosomes
To estimate the efficiency of lipid incorporation, phago-
somal preparation were incubated under the same condi-
tions used in the actin polymerization assay with 50 μM
PIP, 50 μM PIP2, 10 μM PA, or 1 μM PC containing 0.1
μCi of the corresponding radioactive lipid. After 5 min
incubation at 20°C, the samples were centrifuged at
10.000 rpm for 5 min to pellet the phagosomes. The pel-
lets were washed twice and the radioactivity was measured
in pellets and supernatants. The results indicate that 8.2 ±
1.3% PIP, 13.8 ± 0.7% PIP2, 16.8 ± 0.3% PA, and 79.7 ±
0.9% PC were incorporated into phagosomes (mean ±
range, N = 2 or 3). Incorporation of PI and DAG were
assumed similar to those measured for PIP and PA, respec-
tively. Therefore, considering that 1 μM PC, 10 μM DAG,
50 μM PI, 50 μM PIP, 50 μM PIP2, or 50 μM PA where
used to modulate actin nucleation, the membrane con-
centrations after lipid addition were estimated as 54 μM
for PI, 6.6 μM for PIP, 7.1 μM for PIP2, 18 μM for PA, and
9.1 μM for DAG. Since PC is abundant in the membranes
and it affects actin nucleation at very low concentrations,
we considered externally added PC (0.8 μM) and endog-
enous as different species.
TLC separation of radioactive species
Forty μl aliquots of phagosomal samples were incubated
as in the actin assembly assay with different concentra-
tions of ATP and 40 μCi/ml of 32P γ-labelled ATP (10 mCi/
ml, Amersham) at room temperature for different period
of time. When indicated, lipids (labelled or unlabelled) or
water soluble compounds were added. The reaction was
stopped adding 100 μl 1 M HCl and 280 μl methanol/
chloroform (1:1, vol/vol). The organic phase was col-
lected, dried under vacuum and dissolved in chloroform/
methanol/water (75:25:2, vol/vol). Subsequently, the lip-
ids were separated by TLC on Silica Gel G60 plates [pre-
treated with 1% potassium oxalate/2 mM EDTA in meth-
anol/water (1:1, vol/vol)] using a solvent mixture of chlo-Page 13 of 15
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(80:30:26:24:14, vol/vol) [23]. To measure ATP hydroly-
sis in the system, 1 μl of the water phase was loaded in the
TLC plate. The position of phospholipid standards in the
plate was determined as described [4]. The quantification
of 32P-labelled phospholipids separated by TLC was per-
formed with a Fujifilm Imaging Plate and Fujifilm Fluo-
rescent Image Analyzer FLA-2000 equipment (Fujifilm,
Elmsford, NY). As standard, a known amount of γ32P.ATP
was spotted in the TLC plate.
Network modelling
The mathematical model was formulated combining
three sub-models: ATP decay, lipid phosphoryaltion/
dephosphorylation, and actin nucleation. This was sug-
gested by the fact that lipid phosphorylation amounted
only to a very small fraction of ATP consumption and the
actin nucleation did not feed back appreciably into the
ATP and lipid metabolism.
Metabolites and chemical reactions were modelled in
COPASI [24] assuming a single compartment. Internally,
COPASI works with number of molecules. The concentra-
tion units we used can be transformed directly to mole-
cule numbers by specifying the volume. However, the
phagosomal preparation is a complex system where some
interactions occur in a space almost restricted to two
dimensions (the phagosomal membrane), other in the
membrane-buffer interphase and other in the buffer. This
complexity is not taken into account by COPASI. Not-
withstanding, this heterogeneous system has some advan-
tages. The lipid and protein concentrations on the
phagosomal membrane are established by the cell and
they do not depend on the efficiency of the purification
procedure. These may explain the very consistent effect of
lipids and ATP on actin nucleation observed in all phago-
somal preparations tested. In sub-model III (actin polym-
erization), concentration units are arbitrary, a fact that
does not disturb the calculations because we do not pos-
tulate stoichiometric relationships between lipid, ATP and
actin nucleation sites.
Radioactively labelled and unlabelled metabolites were
introduced as separate species sharing the same reactions
(COPASI files are provided as Additional file 1, 2, and 3).
Model parameters were estimated from comparison of the
measured and predicted metabolite concentrations. The
parameter set selected was the one that yielded a mini-
mum of the sum of squared differences between experi-
mental and predicted concentrations. As a routine, the
"Particle Swarm", "Simulated Annealing", or "Nelder-
Mead" methods provided by COPASI were used to obtain
an initial set of parameters. The fitting was refined using
the "Hooke and Jeeves" method with a tolerance of 10-10.
With these method combinations, the same optimal
parameters were obtained irrespective of the starting val-
ues indicating that local minima were avoided.
The quality of the fit for each sub-model was estimated by
a dimensionless number expressing the deviation of the
model from experimental data normalized by the mean
fitted values. This allows comparison of different models
and different data sets. The deviation of the model from
experimental data was calculated from the sum of squared
deviations between data and prediction (SS) provided by
COPASI and from absolute deviations between fitted and
experimental values. The square criterion is in keeping
with the statistical theory of non-linear maximum-likeli-
hood estimation. The absolute deviation criterion gives
usually similar results and it is of more practical value
since it is less affected by occasional large outlier values.
The calculation formulas were: square root (SS/N)/(mean
of fitted values) * 100 or (sum of ABS(experimental-fit-
ted)/N)/(mean of fitted values) * 100. A low (< 20%) per-
centage value is indicative of a good fit.
COPASI provides, in addition to the best parameter set,
standard deviation of the parameter estimates assuming a
maximum-likelihood statistics, which in effect expands a
quadratic surface of the sum-of-squares fit criterion
around the optimal fit. This statistical model was not well-
founded in our data (there was no symmetric ellipsoid
around the minimum, and parameter estimates revealed
interdependence of greatly varying degree). We therefore
adopted a simple intuitive criterion of parameter cer-
tainty: we defined sensitivity for each parameter as the rel-
ative increase of the SS when the parameter was perturbed
and hold constant (upward and downward with two
increments, 1.5 and 2.25 folds). The rest of the parameters
were "re-optimized" to minimize SS. To obtain a scale-
free measure of this sensitivity, we calculated the quantity
Δln SS/Δln "parameter perturbation". In Tables 1, 2, and
3, the average sensitivity when parameters were perturbed
upward and downward by a factor of 2.25 is shown. A sen-
sitivity value of 1.0 says that if a parameter is multiplied
by a factor "n", the SS increases by the same factor. A small
sensitivity (e.g. < 0.1) is indicative of loose determination
of the parameter value by the experimental data. The sen-
sitivity analysis indicates that the fits were satisfactory, but
the estimates of some of the phenomenological parameter
values were less certain.
COPASI can be downloaded from http://www.copasi.org.
The three sub-models, exported from COPASI as SBML
files are included as "Additional Files".
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